Showing results (311-320 of 606) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|July 21, 2022
Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX)Rachael Hunter, Alice Beardmore-Gray, Melanie Greenland, et al.
Pharmacoeconomics - Open|February 28, 2022
Implications of Payment for Acute Myocardial Infarctions as a 90-Day Bundled Single Episode of Care: A Cost of Illness AnalysisKeith B Allen, James E Alexander, Joshua N Liberman, et al.
Pharmacoeconomics - Open|December 14, 2023
The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and SpainBérengère Macabeo, Théophile Rotrou, Aurélie Millier, et al.
Pharmacoeconomics - Open|December 13, 2023
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in SwedenMaria Polyzoi, Mattias Ekman, Anja Reithmeier, et al.
Pharmacoeconomics - Open|November 2, 2023
Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United StatesAhmed Salem, Elizabeth M La, Desmond Curran, et al.
Pharmacoeconomics - Open|November 1, 2023
Specialist Palliative Care and Health Care Costs at the End of LifePatricia Kenny, Dan Liu, Denzil Fiebig, et al.
Pharmacoeconomics - Open|September 14, 2023
Budget Impact Analysis of Risperidone Use and Adverse Event Monitoring in Autism Spectrum Disorder in Brazil: Assessment of Theoretical Versus Real DataLuis Phillipe Nagem Lopes, Alexander Itria, Luciane Cruz Lopes
Pharmacoeconomics - Open|September 25, 2023
Cost-Effectiveness of Non-pharmacological Interventions for Mild Cognitive Impairment and Dementia: A Systematic Review of Economic Evaluations and a Review of ReviewsGillian Eaglestone, Evdoxia Gkaintatzi, Harmony Jiang, et al.
Pharmacoeconomics - Open|July 15, 2023
A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in MexicoJuan Carlos Garnica-Cuellar, Enrique Morales-Villegas, Carmen Alicia López-Forero, et al.
Pharmacoeconomics - Open|January 26, 2019
Cost Effectiveness of Avelumab for Metastatic Merkel Cell CarcinomaAsh Bullement, Paul Nathan, Anna Willis, et al.
Pageof 61